Literature DB >> 18825487

Molecular basis of complement factor I (CFI) polymorphism: one of two polymorphic suballeles responsible for CFI A is Japanese-specific.

Isao Yuasa1, Mayumi Nakagawa2, Kazuo Umetsu3, Shinji Harihara4, Aya Matsusue5, Hiroaki Nishimukai6, Yasuo Fukumori7, Naruya Saitou8, Kyung Sook Park9, Feng Jin10, Gérard Lucotte11, Prasanta K Chattopadhyay12, Lotte Henke13, Jürgen Henke13.   

Abstract

Isoelectric focusing has revealed that human complement factor I (CFI) is controlled by two polymorphic alleles, CFI(*)A and CFI(*)B, and a few rare variant alleles. In this study the molecular basis of the CFI polymorphism was investigated in 174 Japanese. The CFI(*)A was divided into two suballeles, CFI(*)As (R201S) and CFI(*)Ah (R406H). CFI(*)Aj, a rare variant allele originating from CFI(*)Ah, had an additional mutation (R502L). The distribution of these three mutations and two registered SNPs was investigated in a total of 2,471 individuals in 20 populations from various areas, and six haplotypes were observed. Haplotype H3, which is characterized by CFI(*)As, was found only in Far East populations: the frequencies were about 0.03 in the main island of Japan and lower than 0.01 in Okinawa and Korea. Haplotype H5, characterized by CFI(*)Ah, prevailed almost exclusively in East Asians and was observed at the highest frequencies in southern Chinese Han and Thais. CFI(*)Ah must have arisen in a southeastern part of Asia and thereafter have spread to neighboring populations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18825487     DOI: 10.1007/s10038-008-0337-4

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  25 in total

1.  Mechanism of action of the C3b inactivator: requirement for a high molecular weight cofactor (C3b-C4bINA cofactor) and production of a new C3b derivative (C3b').

Authors:  S Nagasawa; R M Stroud
Journal:  Immunochemistry       Date:  1977 Nov-Dec

2.  Genetic origins of the Japanese: a partial support for the dual structure hypothesis.

Authors:  K Omoto; N Saitou
Journal:  Am J Phys Anthropol       Date:  1997-04       Impact factor: 2.868

3.  Mapping of the human complement factor I gene to 4q25.

Authors:  R Shiang; J C Murray; C C Morton; K H Buetow; J J Wasmuth; A H Olney; W G Sanger; G Goldberger
Journal:  Genomics       Date:  1989-01       Impact factor: 5.736

4.  Factor I (C3b inactivator) polymorphism among five populations in Eurasia.

Authors:  I Yuasa; K Umetsu; K Suenaga; K Ito; M Iha; H Hirata; M Robinet-Lévy; T Inoue; K Okada
Journal:  Hum Hered       Date:  1988       Impact factor: 0.444

5.  The molecular basis of hereditary complement factor I deficiency.

Authors:  T J Vyse; B J Morley; I Bartok; E L Theodoridis; K A Davies; A D Webster; M J Walport
Journal:  J Clin Invest       Date:  1996-02-15       Impact factor: 14.808

6.  Biosynthesis and postsynthetic processing of human C3b/C4b inactivator (factor I) in three hepatoma cell lines.

Authors:  G Goldberger; M A Arnaout; D Aden; R Kay; M Rits; H R Colten
Journal:  J Biol Chem       Date:  1984-05-25       Impact factor: 5.157

7.  Male demography in East Asia: a north-south contrast in human population expansion times.

Authors:  Yali Xue; Tatiana Zerjal; Weidong Bao; Suling Zhu; Qunfang Shu; Jiujin Xu; Ruofu Du; Songbin Fu; Pu Li; Matthew E Hurles; Huanming Yang; Chris Tyler-Smith
Journal:  Genetics       Date:  2006-02-19       Impact factor: 4.562

8.  Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome.

Authors:  V Fremeaux-Bacchi; M-A Dragon-Durey; J Blouin; C Vigneau; D Kuypers; B Boudailliez; C Loirat; E Rondeau; W H Fridman
Journal:  J Med Genet       Date:  2004-06       Impact factor: 6.318

9.  Arlequin (version 3.0): an integrated software package for population genetics data analysis.

Authors:  Laurent Excoffier; Guillaume Laval; Stefan Schneider
Journal:  Evol Bioinform Online       Date:  2007-02-23       Impact factor: 1.625

10.  Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndrome.

Authors:  David Kavanagh; Anna Richards; Marina Noris; Richard Hauhart; M Kathryn Liszewski; Diana Karpman; Judith A Goodship; Veronique Fremeaux-Bacchi; Giuseppe Remuzzi; Timothy H J Goodship; John P Atkinson
Journal:  Mol Immunol       Date:  2007-06-26       Impact factor: 4.407

View more
  3 in total

1.  A hypervariable STR polymorphism in the complement factor I (CFI) gene: Asian-specific alleles.

Authors:  Isao Yuasa; Yoshito Irizawa; Hiroaki Nishimukai; Yasuo Fukumori; Kazuo Umetsu; Nori Nakayashiki; Naruya Saitou; Lotte Henke; Jürgen Henke
Journal:  Int J Legal Med       Date:  2009-08-20       Impact factor: 2.686

2.  Genetic variations in complement factors in patients with congenital thrombotic thrombocytopenic purpura with renal insufficiency.

Authors:  Xinping Fan; Johanna A Kremer Hovinga; Hiroko Shirotani-Ikejima; Yuka Eura; Hidenori Hirai; Shigenori Honda; Koichi Kokame; Magnus Mansouri Taleghani; Anne-Sophie von Krogh; Yoko Yoshida; Yoshihiro Fujimura; Bernhard Lämmle; Toshiyuki Miyata
Journal:  Int J Hematol       Date:  2016-02-01       Impact factor: 2.490

3.  FHR-5 Serum Levels and CFHR5 Genetic Variations in Patients With Immune Complex-Mediated Membranoproliferative Glomerulonephritis and C3-Glomerulopathy.

Authors:  Nóra Garam; Marcell Cserhalmi; Zoltán Prohászka; Ágnes Szilágyi; Nóra Veszeli; Edina Szabó; Barbara Uzonyi; Attila Iliás; Christof Aigner; Alice Schmidt; Martina Gaggl; Gere Sunder-Plassmann; Dóra Bajcsi; Jürgen Brunner; Alexandra Dumfarth; Daniel Cejka; Stefan Flaschberger; Hana Flögelova; Ágnes Haris; Ágnes Hartmann; Andreas Heilos; Thomas Mueller; Krisztina Rusai; Klaus Arbeiter; Johannes Hofer; Dániel Jakab; Mária Sinkó; Erika Szigeti; Csaba Bereczki; Viktor Janko; Kata Kelen; György S Reusz; Attila J Szabó; Nóra Klenk; Krisztina Kóbor; Nika Kojc; Maarten Knechtelsdorfer; Mario Laganovic; Adrian Catalin Lungu; Anamarija Meglic; Rina Rus; Tanja Kersnik Levart; Ernesta Macioniene; Marius Miglinas; Anna Pawłowska; Tomasz Stompór; Ludmila Podracka; Michael Rudnicki; Gert Mayer; Romana Rysava; Jana Reiterova; Marijan Saraga; Tomáš Seeman; Jakub Zieg; Eva Sládková; Natasa Stajic; Tamás Szabó; Andrei Capitanescu; Simona Stancu; Miroslav Tisljar; Kresimir Galesic; András Tislér; Inga Vainumäe; Martin Windpessl; Tomas Zaoral; Galia Zlatanova; Mihály Józsi; Dorottya Csuka
Journal:  Front Immunol       Date:  2021-09-10       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.